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Abstract 10 
 11 
Motivated by potential benefits such as sensor miniaturization, multiplexing opportunities and higher 12 
sensitivities, refractometric nanoplasmonic biosensing has profiled itself in a short time span as an 13 
interesting alternative to conventional SPR biosensors. This latter conventional sensing concept has 14 
been subjected during the last decades to strong commercialization, thereby strongly leaning on well-15 
developed thin-film surface chemistry protocols. Not surprisingly, the examples found in literature 16 
based on this sensing concept are generally characterized by extensive analytical studies of relevant 17 
clinical and diagnostic problems. In contrast, the more novel LSPR alternative finds itself in a much 18 
earlier, and especially, more fundamental stage of development. Driven by new fabrication 19 
methodologies to create nanostructured substrates, published work typically focuses on the novelty of 20 
the presented material, its optical properties and its use – generally limited to a proof-of-concept – as a 21 
label-free biosensing scheme. Given the different stages of development both SPR and LSPR sensors find 22 
themselves in, it becomes apparent that providing a comparative analysis of both concepts is not a 23 
trivial task. Nevertheless, in this review we make an effort to provide an overview that illustrates the 24 
progress booked in both fields during the last five years. First, we discuss the most relevant advances in 25 
SPR biosensing, including interesting analytical applications, together with different strategies that 26 
assure improvements in performance, throughput and/or integration. Subsequently, the remaining part 27 
of this work focuses on the use of nanoplasmonic sensors for real label-free biosensing applications. 28 
First, we discuss the motivation that serves as a driving force behind this research topic, together with a 29 
brief summary that comprises the main fabrication methodologies used in this field. Next, the sensing 30 
performance of LSPR sensors is examined by analyzing different parameters that that can be invoked in 31 
order to quantitatively assess their overall sensing performance. Two aspects are highlighted that turn 32 
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out to be especially important when trying to maximize their sensing performance, being 1) the targeted 33 
functionalization of the electromagnetic hotspots of the nanostructures, and 2) overcoming inherent 34 
negative influence that stem from the presence of a high refractive index substrate that supports the 35 
nanostructures. Next, although few in numbers, an overview is given of the most exhaustive and 36 
diagnostically relevant LSPR sensing assays that have been recently reported in literature, followed by 37 
examples that exploit inherent LSPR characteristics in order to create highly integrated and high-38 
throughput optical biosensors. Finally, we discuss a series of considerations that, in our opinion, should 39 
be addressed in order to bring the realization of a stand-alone LSPR biosensor with competitive levels of 40 
sensitivity, robustness and integration (when compared to a conventional SPR sensor) much closer to 41 
reality. 42 
  43 
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1. Introduction 48 
Driven by the increasing need for sensitive, fast, cost-effective, low-reagent-consumption and ease-of-49 
use biosensors for applications in the clinical and biomedical field, a myriad of biosensing configurations 50 
and devices have appeared in the literature during the last decades. In connection to this, a major 51 
unmet diagnostic demand is the necessity of reliable compact Point-of-care (POC) devices, which can 52 
provide instant results in any place at any time, offering the possibility of personalized care that may 53 
result in an improved health outcome. From the currently well-defined technologies, optical biosensors 54 
show unquestionable advantages as compared to other biosensing technologies, including high 55 
immunity to electromagnetic (EM) interferences, better stability in aggressive environments, and above 56 
all, the ability of providing label-free measurements combined with their potential for multiplexing and 57 
miniaturization, offering a great prospective for highly integrated devices. Among the different optical 58 
sensing platforms, those based on the use of plasmonic structures meet many of these benefits, and 59 
hence, are considered to be key components for the creation of advanced biosensing platforms.  60 
 61 
Plasmonics is the field  that studies the interaction of EM radiation with metals. Resonant coupling of 62 
optical waves to the free electrons of a metal can give rise to surface bound EM modes that are 63 
commonly referred to as Surface Plasmons (SPs). These plasmonic modes are typically excited at the 64 
interface of a noble metal and a dielectric, thereby complying to the SP excitation condition that 65 
demands the presence of two adjacent materials with oppositely signed optical constants. SPs exhibit 66 
their maximum field intensity at the metal-dielectric interface, while decaying evanescent waves 67 
penetrate into both adjacent media. The evanescent field that penetrates into the surrounding dielectric 68 
provides the SP with a sensing probe that is extremely sensitive to changes of the refractive index (RI) 69 
close to the metal surface. It is this property that is exploited when plasmonic structures are used as 70 
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refractometric sensing platforms: changes that occur in the vicinity of the metal-dielectric interface, 71 
such as the attachment or recognition of biomolecules, induce RI changes that alter the excitation 72 
conditions of the SP. These changes can be tracked over time, providing a measurable quantity for the 73 
label-free detection of biomolecular interactions. SPs generally come in two varieties: propagating SPs 74 
excited on thin metal films, commonly referred to as Surface Plasmon Polaritons (SPPs) or Surface 75 
Plasmon Resonances (SPRs), and Localized Surface Plasmon Resonances (LSPRs), the latter being SPs 76 
excited on sub-wavelength-sized metal nanoparticles (see Figure 1).  77 
LSPRs provide metal nanoparticles with exemplified absorption- and scattering cross-sections at specific 78 
wavelengths, opening up a world full of bright and vividly colored nanostructures in the VIS and NIR 79 
region of the light spectrum. Theoretical interest in the optical properties of metal nanoparticles dates 80 
back to the 20th century [1]. However, it has not been until recently, that, accompanied by the eruption 81 
of nanotechnology, providing new methods to fabricate, structure and measure nanoscale materials, 82 
that nanoplasmonics has experienced an enormous experimental boost leading to a deeper 83 
comprehension of these light-metal interactions. As a consequence, the optical properties of metal 84 
nanoparticles have led to many new applications in either new or already existing fields of interest, such 85 
as photovoltaic devices [2, 3], nanophotonics applications [4], biomedical applications such as imaging, 86 
drug delivery, photothermal therapy and therapeutics [5, 6] and, of course, biomolecular sensing [7]. 87 
In contrast, propagating SPRs have been around for approximately half a century now, providing SPR-88 
based biosensors with sufficient time to position themselves as a landmark label-free biosensing 89 
platform. Nowadays, the initial potential of SPR sensors has surpassed all expectations, establishing this 90 
sensing concept as a routine analytical instrument. Motivated by both its simplicity and versatility, its 91 
scope of applications has spread into a wide range. In this regard, affinity and kinetic studies or simple 92 
detection of compounds have met a systematic, easy, fast, real-time and usually sensitive manner to be 93 
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done. Its validity as a reference optical biosensor is reflected from the number of yearly publications 94 
covering application areas ranging from environmental monitoring and food quality to safety, and 95 
clinical diagnostics. The implementation of SPR imaging (SPRi) as an alternative SPR-based approach that 96 
promotes in-parallel analyses, has expanded its use into the pharmaceutical research and the overall 97 
medical field, with applications including high throughput screening, protein-protein interaction studies 98 
and drug discovery, amongst others. Besides, the continuous progress in physics, engineering, material 99 
science and nanotechnology has allowed the introduction of performance-enhancing modifications to 100 
conventional SPR sensor configurations. Of particular importance is the pursuit of improvements in the 101 
three most reported weaknesses of SPR biosensors: sensitivity, throughput capabilities and potential for 102 
miniaturization.  103 
To this end, LSPR-based biosensing platforms are considered to be the next-generation plasmonic 104 
sensing platforms. Their inherent advantages over conventional SPR sensors are expected to fill in the 105 
gaps left open by SPR sensors. Judging by the exponentially increasing number of publications in this 106 
topic during the last decade (see Figure 2), it is not a surprise that the field of nanoplasmonic sensing 107 
has been subjected to a great scientific interest. So far, most effort has been directed towards the 108 
fabrication and development of the employed nanostructures, the evaluation of its physical and optical 109 
properties and its potential to perform biosensing, although this latter concept is typically limited to a 110 
proof-of-concept point of view.  111 
In literature, several works have already extensively covered the field of refractometric LSPR sensing in a 112 
very extensive and general manner [8-10]. In this review, we mainly focus on the progress made in this 113 
field during the last 4-5 years, paying special attention to the use of refractometric nanoplasmonic 114 
sensors for real biosensing applications, while identifying the implications, requirements and pending 115 
challenges in order to achieve fully operative devices with appropriate levels of sensitivity, robustness 116 
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and integration potential, that can make them ultimately competitive with conventional SPR-based 117 
devices. 118 
2. SPR Biosensing: Improving Performance and Design 119 
Despite being the most widely used label-free optical biosensor, SPR sensors suffer from several 120 
limitations when compared with other optical label-free sensing techniques, which can be traced back to 121 
fundamental properties of SPRs. First of all, the penetration depth of a SPR´s evanescent field into its 122 
neighboring dielectric is typically hundreds of nm, thereby being much larger than typical sizes of 123 
biomolecules [11]. Hence, in some analytical and clinical areas where concentrations to be detected are 124 
particularly low or when the target structure is much smaller than this penetration depth, the molecules 125 
occupy only a fraction of this evanescent field that acts as a sensing probe, thereby offering a resolution 126 
for the detection of analytes that is typically not sufficient. Furthermore, the characteristic SPR wave-127 
vector exceeds that of light traveling through the same dielectric. Excitation of SPRs is therefore only 128 
possible when this momentum mismatch is overcome, something that can be achieved by enlarging the 129 
wave-vector of the excitation light. Generally, this is accomplished by using a prism-coupled 130 
Kretschmann excitation scheme, making the sensor configuration significantly bulky. Upon addition of 131 
the microfluidics, optical components and other hardware, most commercialized SPR biosensors are still 132 
portable, but their size and weight is not optimal, and far from ideal for LOC or POC devices. Finally, the 133 
large propagation distances of SPRs (10-100 μm) limit the minimum sensing area, thus strongly reducing 134 
high-throughput capabilities for multiplexed measurements. Not surprisingly, much effort is being put in 135 
overcoming these that are considered the weakest points of these biosensors. In the following 136 
paragraphs an overview is given of recent works that point toward this direction.  137 
Although highly useful for real-time detection and with a proven effectiveness in the monitorization and 138 
characterization of biomolecular interactions, the sensitivity of refractometric SPR sensors usually 139 
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ranges between 10-6-10-7 refractive index units (RIUs) [11, 12] and a limit of detection (LOD) of 140 
approximately 0.5-1 pg/mm2. In terms of concentration sensitivities, these values would correspond to 141 
LODs in the pM-nM range, when optimal surface biofunctionalization has been previously done and 142 
high-quality biological reagents are employed. This limited sensitivity, which can be beaten by other 143 
label-free optical configurations [13], becomes a more critical factor for the direct detection of small 144 
analytes at very low concentrations, for clinical application where the concentrations can range from pM 145 
to fM, or for single-molecule detection. Most of the proposed strategies to overcome this problem tend 146 
to be based on the expansion of the detection assay with additional steps, such as the addition of 147 
successive reagents or compounds in a specific layer-based system. These approaches induce an overall 148 
increase of molecular weight and hence, a significant enhancement of the measured signal. An 149 
illustrative example comprises sandwich formats where secondary recognition elements are added, 150 
either free or labeled with for instance a nanoparticle [14-19]. Despite the improved sensing 151 
performance, this methodology complicates overall procedures, since more reagents are required, and 152 
analysis times are inevitably lengthened.  153 
In the case that simplicity and rapidity are considered to be essential features, sensitivity enhancing 154 
strategies that affect the optics, the metallic surface, or the SPR excitation methodology, might be much 155 
more appropriate. For an extensive overview on these different approaches, we refer to the work 156 
carried out by Homola et al. [11]. The use of alternative SPR excitation methods, different from the 157 
conventional prism-based coupling scheme, such as the use of waveguide-[20, 21], fiber-optic-[20, 21], 158 
or grating-based light-coupling [22], have been considered as sensitivity enhancing strategies [23]. 159 
However, a recent theoretical study demonstrated that the sensitivity of SPR sensing is reaching its limit 160 
regardless of the employed coupling configuration and/or modulation technique (wavelength, angle, 161 
intensity) [24]. This work proclaims that most improvements may come from the optimization of the SPR 162 
itself, that is, by changing properties of either the employed thin metal films, or their dielectric 163 
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surroundings. To this end, it has been demonstrated that the use of multilayers built out of noble and 164 
ferromagnetic metals (Au/Co/Au), which exploit magneto-optical activity in combination with SPRs, 165 
result in a significant four-fold enhancement of the sensing performance of a conventional SPR 166 
biosensor [25, 26]. Also, Long-Range Surface Plasmon Resonance (LR-SPR) sensors have proven 167 
pronounced sensitivity improvements, reaching values of approximately 2.5·10-8 RIU [27]. Compared to 168 
conventional SPR sensors, where the metal substrate is comprised between different dielectrics, LR-169 
SPRs can only be excited when the thin metal film is comprised between two dielectric media with 170 
similar RI (i.e. the sensing medium - typically being the buffer used for biosensing applications - and a 171 
thin layer of Teflon). LR-SPRs propagate along the metal film exhibiting much larger penetration depths 172 
(200-1400 nm), which becomes especially relevant for the detection of large targets such as cells and 173 
bacteria yielding 2.5- to 5.5-fold better sensitivities [28], or to deeply study cellular response such as cell 174 
volume changes [29]. 175 
Also the microfluidics and the sample transport to the gold sensing surface have a strong impact on the 176 
sensing performance in terms of sample dispersion and overall response time. Homola’s group has 177 
designed a dispersionless microfluidic system which minimizes the mixing of samples and enhances the 178 
sample transport directly to the surface by incorporating two pairs of in- and output ports for sample 179 
injection. Controlled valve-mediated port-switching allows for the regulation of the sample injection, 180 
assuring that the change of sample volumes takes place near the sensing surface [30]. These 181 
modifications improve the sensing performance, exhibiting a RI resolution of 1.3·10-7 RIU [31]. 182 
Application of this strategy to oligonucleotide hybridization assays has led to a significant detectability 183 
improvement when compared to traditional microfluidics, achieving LODs as low as 70 pM [30], while its 184 
successful implementation has also been expanded to protein detection in diluted plasma [31, 32]. 185 
Besides, as recently demonstrated by Lynn et al., geometrical aspects of the flow cell, such as the 186 
channel height, can also have a pronounced impact on the sensitivity of SPR sensing [33]. Finally, by 187 
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decreasing the size of the read-out area to a minimum, Kvasnička et al. have shown that the LOD can be 188 
pushed down to detection levels of a few hundreds of molecules [34]. 189 
Next to sensitivity-enhancing strategies, much interest is also still focused on the improvement of the 190 
multiplexing and miniaturization capabilities of these sensors. SPR sensors can be noticeably 191 
miniaturized and/or integrated if the prism-coupled excitation scheme is replaced by one of the 192 
previously mentioned alternatives such as dielectric waveguides, end-fire coupling, or diffraction 193 
gratings grafted into the plasmonic substrate. Nevertheless, each of these methodologies adds more 194 
complexity to both the fabrication process and the user-friendliness of the device. Other strategies that 195 
proclaim smaller and more integrated devices include those that leave out the pump that delivers 196 
solutions to the flow cell (an external pump is still necessary), or the use of integrated microfluidics. The 197 
latter option not only leads to more compact devices, but also opens up possibilities to improve the 198 
sensor´s capabilities to carry out multiplexed measurements. In this line, some of the reported SPR 199 
sensors incorporate several measurement channels [11], although most of them are limited to at most 200 
10 channels. A second approach that provides the ability of carrying out multiplexed measurements is 201 
embodied by the SPR imaging (SPRi) concept [35, 36]. This technique, which is considered a large 202 
qualitative step forward in the field to microarray-based sensing, has become a valuable tool in 203 
proteomics, facilitating the simultaneous analysis of hundreds of biomolecular interactions. Essentially, 204 
a SPRi consists of an expanded light source projected onto a patterned gold surface, where the reflected 205 
light is imaged onto a CCD camera. Image processing algorithms allow for real-time contrast 206 
measurements of all the active spots, providing a quantitative measure for the amount of adsorbed 207 
molecules (refractive index change) on each sensing area. Different SPRi instruments are currently 208 
commercialized but, unfortunately, the sensitivity of these devices appear to be typically lower than the 209 
conventional SPR biosensors [24], and eventually, amplification steps are included in order to enhance 210 
the detectability. From a practical point of view, SPRi instruments commonly have restrictions in terms 211 
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of sample delivery, since they are limited to a single analyte/solution flown at a time on a multiple-212 
ligand spotted surface. The use of appropriate microfluidics  facilitate the evaluation of parallel and 213 
simultaneous analyte solutions and in case of being highly required, for internal referencing [37]. A few 214 
attempts have been done in order to develop microfluidic flow cell arrays with the aim of performing 215 
parallel and individualized throughput delivery. Eddings et al.[38, 39] have developed a 3D microfluidic 216 
flow cell array for the independent delivery of up to 48 different analyte solutions, either for the in-situ 217 
patterning of the spot or for the secondary delivery of the target solutions. More complex is for instance 218 
the flow cell developed by Ouellet et al. [40] consisting of a PDMS microfluidic flow array of 264 219 
independent chambers with individual volumes of up to 700 pL. This system is also designed to allow for 220 
the recovery of bound sample for further downstream processing. Recently, both nanostructures and a 221 
digital droplet-based 2D microfluidic interfaces have been combined in a SPRi, to enhance both 222 
sensitivity and improve the automation of simultaneous analyses requiring ultra-low sample volumes 223 
[41-43]. 224 
3. Nanoplasmonic Biosensing 225 
3.1 Motivation, Instrumentation and Fabrication 226 
One could argue that the current increase in interest in nanoplasmonic sensing platforms is nothing 227 
more than the logical consequence of nanotechnology pushing conventional SPR sensing towards new 228 
frontiers. Either way, the most important question that needs to be answered is whether this evolution 229 
is worth the effort. Inherent benefits of metal nanostructures offer possibilities that can difficultly be 230 
met by conventional SPR sensors. Compared to SPRs, where the propagating nature of the plasmonic 231 
mode assures large effective sensing areas, the strong EM field confinement and the localized nature of 232 
LSPRs limits the minimum sensing area of metal nanostructures to their size. Combined with the 233 
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possibility of exciting the LSPRs with direct EM illumination, and thus becoming unnecessary the use of 234 
bulky coupling methodologies, the use of metal nanoparticles offers very promising opportunities for 235 
sensor miniaturization and multiplexing. Besides the strong EM field confinement of LSPRs ensures 236 
smaller penetration depths of the evanescent field into the surrounding dielectric. As a direct 237 
consequence, biomolecules attached to the nanoparticle surface occupy a much larger fraction of the 238 
evanescent field, raising the expectations of exceptional sensitivities for the detection of tiny 239 
biomolecules in low amounts. 240 
In general, a nanoplasmonic biosensor consists of a nanostructured substrate with compatible 241 
microfluidics. The LSPR of the nanostructures can be excited by a UV-VIS light source, while a 242 
spectrometer collects the necessary light. For high nanostructure surface densities, extinction 243 
measurements are the easiest way to characterize the optical properties (See Figure 3.A). In this case, 244 
light is shed on the plasmonic nanostructures and the transmitted light is analyzed with a spectrometer. 245 
However, in the limit of single particle sensing, a much higher contrast is needed between the excitation 246 
light and the light absorbed by the nanoparticles. In those cases, scattering measurements are 247 
preferred. These high signal-to-background levels can be achieved by dark-field (DF) microscopy or total 248 
internal reflection (TIR) spectroscopy. As the size of the particles is reduced, the scattering cross section 249 
becomes smaller and absorption becomes dominant, making extinction measurements more desirable. 250 
In DF microscopy (transmission configuration) a DF condenser is used to focus a hollow – high numerical 251 
aperture – cone on the nanostructured substrate. Then, the scattered light dispersed by the 252 
nanostructures can be collected by a microscope objective with a lower numerical aperture (Figure 3.B). 253 
In contrast, in TIR microscopy, the LSPR is excited in a prism-coupled TIR configuration (Figure 3.C), 254 
thereby also using a microscope objective to collect the scattered light, but, in this case, without any 255 
restriction on its numerical aperture. 256 
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Nanostructured substrates employed in the nanoplasmonic biosensors can be divided in those based on 257 
top-down or bottom-up fabrication methodologies. While the former group relies on lithographical 258 
patterning techniques, the latter one is based on chemically synthesized colloidal nanoparticles that are 259 
further deposited on substrates. Herein, we only point out the basics of both fabrication concepts. For a 260 
more detailed and extensive information on the fabrication of nanoplasmonic structures, we refer to the 261 
review by Jones et al. [44]. The current variety and extraordinary optical properties of synthesized 262 
nanoparticles can be attributed to great advances in nanotechnology, providing researchers with the 263 
necessary wet chemistry methods that enable precise geometrical nanoparticle engineering. In this 264 
regard, next to spheres [45], rods [46-48], plates [49], triangles [50, 51], (bi)pyramids [52-54], cubes [55, 265 
56], tubes [57], stars [58] or prisms [59], also hybrid- and alloy nanoparticles have been fabricated [60], 266 
such as for example core-shell particles [61-64], nanoflowers [65] or nanorice [66]. In all these cases, the 267 
nature of colloidal nanoparticles imposes serious drawbacks on their use as biosensors in solution (i.e. 268 
colorimetric aggregation-based assays). Changes in the ionic strength, pH or buffer temperature, can 269 
lead to the particle precipitation. Besides, surface biofunctionalization protocols can screen or modify 270 
the charge distribution yielding a rupture of the colloidal equilibrium. To avoid these difficulties, 271 
attachment of the colloidal nanostructures to a solid support can be the best alternative or even a 272 
prerequisite. An additional benefit is its compatibility with microfluidics for in-flow sensing assays. To 273 
this end, different methodologies have been developed that aim at attaching the colloidal nanoparticles 274 
to previously functionalized surfaces via either covalent or electrostatic linkage strategies. Thiol- or 275 
amino- modified glass surfaces can strongly attach gold nanoparticles to the surface, although 276 
sometimes this functionalization step can be especially tricky with particles that require a stabilizer layer 277 
on the surface to avoid aggregation, like in the case of nanorods, nanoplates or other kind of structures 278 
[49, 54]. These surface modifications usually hinder an efficient and reproducible coverage of the solid 279 
support. In an attempt to overcome this problem, additional steps are typically required involving the 280 
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exchange of this protective layer with other functionalized compounds (i.e. PEGylated compounds, 281 
thiolated compounds with carboxylic acid, biotin, etc). This step subsequently allows for binding to 282 
appropriately modified surfaces (amino-, thiol-, avidin-modified or opposite-charged surfaces so that 283 
electrostatic interactions occur [58, 67, 68]). An attractive alternative consists of directly growing the 284 
nanostructure on the substrate [69]. The surface density of immobilized nanoparticles can be controlled 285 
by optimizing parameters such as the concentration of the colloidal nanoparticle solution, the 286 
incubation time, or the temperature, making it possible to obtain highly-dense or very sparse surface 287 
concentrations. For sparse density, inter-particle discrimination becomes possible, enabling the spectral 288 
monitoring of a single nanostructure. It should be noted that almost all these immobilization strategies 289 
lead to a random nanoparticle surface distribution, yielding low control of both position and orientation. 290 
This issue can be overcome by carrying out a previous ordered functionalization of the substrate, for 291 
instance, by carefully modifying the surface at specific positions that finally results in an arrayed-based 292 
distribution. 293 
The most typical top-down fabrication approaches include conventional lithography such as 294 
photolithography, electron beam lithography (EBL) or focused ion beam lithography (FIB), allowing for 295 
the formation of ordered arrays of nanometric structures with well-defined shapes and sizes. Although 296 
widely used, these techniques are slow and high-cost, and despite high levels of resolution, typically 297 
limit the patterning area to only a few μm2. On the other side, conventional photolithography permits 298 
faster, parallel and large-scale fabrication at the expense of lower resolution. A different approach for 299 
large-scale and low-cost creation of plasmonic nanostructures is offered by colloidal lithography 300 
techniques, such as nanospheres lithography (NSL) [70-72], or hole-mask colloidal lithography (HCL) 301 
[73]. In both methods, the self-assembled layer of nanospheres onto the substrate is used as a sacrificial 302 
mask for the generation of nanostructured substrates. With NSL, hexagonal self-assembly of 303 
nanospheres in close-packed layers renders highly ordered patterning, whereas HCL, characterized by 304 
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short-range ordered arrays of nanostructures, offers more versatility in terms of particle geometry. 305 
Another fabrication methodology that currently receives much attention is nanoimprint lithography. 306 
This technique relies on the use of reusable master stamps, which can be either hard (rigid) [74], or soft 307 
(elastomeric) [75], that are used to imprint or transfer predefined patterns onto almost any desired 308 
substrate. These patterns are typically used as a mask for successive fabrication steps. Due to the 309 
reusability of the master stamps, and even their tunability in the case of soft stamps [76], nanoimprint 310 
lithography is considered a low-cost technique with potential for high-throughput fabrication of sub-311 
micron structured substrates. Using this fabrication methodology, large nano-patterned areas of domes 312 
[77], cavities [78], holes [79], and dots/disks [80-82] have been reported. A different approach is offered 313 
by nanostencil lithography. Based on shadow mask deposition, and having the additional benefit of not 314 
requiring any resist-processing, baking, or solvent-use, this technique fabricates dense nanostructured 315 
substrates with high resolution [83], such as nanodots [84], or nanorods[85], and can even be extended 316 
for the creation of nanoplasmonic structures on flexible substrates[86, 87]. Next to these 317 
abovementioned approaches, other top-down methods that are worth mentioning include the use of 318 
porous alumina templates for the creation of vertical nanorods [88] and nanotubes [89], the direct seed-319 
mediated growth of nanoplates directly on top of surfaces [69], the use of interference lithography [90], 320 
or the creation of nanoparticle cluster arrays using a hybrid top-down/bottom-up approach [91].  321 
3.2 Sensing Performance of Refractometric LSPR Biosensors 322 
3.2.1. Sensitivity Considerations 323 
The ability with which metal nanostructures can detect RI changes is generally expressed in terms of 324 
their bulk sensitivity ηB, that is, the linear dependence of resonance wavelength λLSPR on the 325 
homogeneous bulk RI changes of the dielectric environment: 326 
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Next to ηB, a second property that strongly influences the sensing performance is the ability with which 327 
these spectral shifts can be discriminated, something that is normally taken into account by considering 328 
the full-width-half-maximum (Γ) of the resonance peak. Both quantities are often combined in a 329 
generalized performance-assessing figure-of-merit (FOM) parameter, defined as: 330 
, 331 
This parameter, both valid in wavelength and energy scale [92], provides an easy way for the 332 
performance assessment of nanoplasmonic structures whose spectral response is described by a 333 
Lorentzian peak. However, to expand its use to other nanometric structures that exhibit more complex 334 
spectral responses, Becker et al. proposed an alternative FOM-quantity by considering relative peak 335 
intensity changes at the wavelength where the slope dI/dλ is maximized [93]: 336 
 
Both ηB, FOMB and FOMB* parameters are extensively used and considered to be good indications for 337 
the bulk sensing performance of nanoplasmonic sensors [78, 92-99]. Depending on the specificity of the 338 
employed sensing platform, different, but equally useable FOM definitions can be found. In this regard, 339 
Offermans et al. devised a generalized scaling law for lattice-based nanoplasmonic sensing schemes, in 340 
which the employed FOM parameter is uniquely determined by geometrical lattice properties [100]. 341 
However, from a biosensing point-of view, it is much more interesting to probe the EM field distribution 342 
of a nanoplasmonic sensor close to the metal surface, which is the region where the biomolecular 343 
interactions take place. For this, a surface sensitivity parameter ηS can be defined that accounts for the 344 
near-field sensing performance: 345 
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In this expression, d, is the thickness of a very thin adsorbed layer that homogeneously coats the metal 346 
nanostructure, with a refractive index that is representative for organic molecules. Again, the 347 
accompanying figure-of-merit can be defined by: FOMS = ηS/ Γ, which in the limit of d0 can be used to 348 
mutually compare the surface sensing performance of different (nano-)plasmonic sensing schemes. 349 
When considering the simplest type of metal colloids, the most archetypical example of a 350 
nanoplasmonic sensor is based on spherical gold nanoparticles. However, the strongly blue-shifted LSPR 351 
inherent to this particle-shape (λLSPR < 600 nm) results in a spectral overlap with the interband transition 352 
of gold. As a consequence, sensors based on spherical nanoparticles not only exhibit low bulk 353 
sensitivities (ηB < 120 nm·RIU
-1), but also broad peak widths (Γ > 100 nm) [101]. The resulting FOM 354 
parameters, which are an order of magnitude smaller than those corresponding to SPR sensors, limit 355 
their potential use as label-free refractometric LSPR nanobiosensors.  356 
In contrast, a much better sensing performance is obtained when rod-shaped nanostructures are 357 
considered. For these particles, variation of their longitudinal axes allows for the spectral tuning of their 358 
LSPR, while maintaining relatively low particle volumes [102]. Red-shifting of their plasmon resonance 359 
not only assures larger sensitivities, but also distances their LSPR from the interband transitions of the 360 
employed plasmonic material. The combination of both factors results in enhanced bulk and surface 361 
sensing performances when compared to spherical nanoparticles. However, most interestingly, it has 362 
been shown that although conventional SPR sensors outclass these gold rod-shaped LSPR sensing 363 
platforms in bulk sensing performance by approximately one order of magnitude, their surface sensing 364 
performance dictates a very different behavior: gold nanorods exhibit a surface sensing performance 365 
that is 15% better than that of their SPR-counterpart, while theoretical calculations predict an even 366 
larger improvement [92]. Besides, nanorods exhibit an optimized spectral sensing region when their 367 
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aspect ratios lies between 3 and 4 (λLSPR = 700-800 nm), which can be accessed through precise 368 
nanoparticle engineering [92, 93, 103]. Moreover, the overall sensitivity enhancement of single rod-369 
based LSPR sensors can be duplicated when silver is used as the plasmonic material[47], although silver 370 
has the strong disadvantage of its chemical instability. These results not only demonstrate the potential 371 
of LSPR sensors, profiling them as alternative for conventional SPR sensors, but also emphasize the fact 372 
that when comparing both plasmonic sensing schemes, distinction between bulk and surface FOMs is 373 
mandatory. This discrepancy finds its roots in the different EM field distributions of both plasmon types. 374 
Due to the much larger penetration depths of SPRs into the surrounding dielectric, SPRs possess much 375 
larger sensing volumes for the detection of bulk RI changes. However, when it comes to biosensing, the 376 
spatially more confined EM field distribution of LSPRs assures a larger fractional occupancy of molecules, 377 
assuring better surface sensing performances. For a real comparative study involving both sensing 378 
platforms, only an assessment based on the surface sensing performance paints a realistic picture of the 379 
actual biosensing performance.  380 
Unfortunately, different nanoparticles are usually compared through their bulk sensing performance, 381 
often leaving their surface sensing characteristics out of the equation. For conventional spheroidal 382 
nanostructures, such as spherical and rod-shaped particles, bulk sensitivities tend to range between 100 383 
and 500 nm/RIU. These values can significantly increase for more complex structures [104], such as 384 
bipyramids (540 nm/RIU), nanoprisms (583 nm/RIU) [59], ring-disk nanocavities (648 nm/RIU) [105] or 385 
nanocrosses (1000 nm/RIU) [106]. Either way, the lack of information of their  surface sensing 386 
performance is not that surprising, especially when taking into account the work carried out by Piliarik et 387 
al., in which a gold nanorod is used as an example to illustrate the strong correlation that exists between 388 
the surface sensing performance and the EM field profile of the LSPR [107]. From this work it can be 389 
concluded that for a good assessment of the surface sensing capability of a nanostructure, it becomes 390 
necessary to assure a homogeneous coverage of the nanoparticle´s surface with biomolecules, or, even 391 
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more important, to channel molecule binding uniquely to those regions of the particle that exhibit the 392 
highest sensitivity. This latter approach becomes especially desirable to enhance the surface sensitivity 393 
but simultaneously is really difficult from an experimental point of view, especially when considering 394 
that nanoparticle surface chemistry still lags behind thin film surface modification protocols. As a 395 
conclusion, we can point out that in order to fully exploit the biosensing potential of more complex 396 
nanostructures, the functionalization on the so-called EM hotspots of the structure, typically being sharp 397 
edges, or small cavities, should become the main challenge to be surpassed.  398 
3.2.2. Sensitivity Improvements 399 
As briefly introduced in the previous section, two aspects that turn out to be especially relevant when 400 
trying to maximize the biosensing performance of nanoplasmonic sensors are: (i) the directed 401 
biofunctionalization of the metallic nanostructures leaving the supporting substrate unaltered and (ii) 402 
overcoming intrinsic negative influences that the substrate itself (typically glass/silicon-based materials) 403 
can have on the sensing performance.  404 
Directed Functionalization 405 
The field that offers most margin for the improvement of the LSPR sensing performance is related to the 406 
proper surface functionalization of the plasmonic nanostructures, that is, directed functionalization. 407 
However, this aspect is often under-highlighted in published studies of refractometric LSPR biosensing. 408 
Before going into further detail, it must be mentioned that the functionalization process for SPR sensors 409 
is much more simplified: whereas in thin film sensing biomolecules see a homogeneous gold surface at 410 
which binding can take place, in LSPR sensors part of the underlying substrate is typically exposed, 411 
making undesired non-specific binding events to this substrate easy to occur. In this latter case, ideally 412 
all molecules reaching the nanostructured surface should be anchored solely to the nanostructures, and 413 
preferably, only to those places that find themselves in the vicinity of EM hotspots, where RI sensitivity 414 
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is maximized. However, only few examples exist in literature that proactively attack this problem. Most 415 
probably, inherent complexities related to accurate orthogonal modification of both materials lie at the 416 
heart of the problem: in an ideal system one would functionalize the metallic nanostructures with the 417 
biomolecules at a given desired surface density concentration, while the underlying substrate is blocked 418 
with materials or compounds that assure its inertness to both the immobilized biomolecules and its 419 
corresponding target. A study that exemplifies this very well was carried out by Feuz et al. [108]. In this 420 
work, thin gold nanohole films fabricated on top of a TiO2 substrate are used in combination with a 421 
proof-of-concept protein sensing assay (detection of Neutravidin by biotinylated surfaces), to provide a 422 
comparable study that demonstrates that by assuring both previously mentioned demands, the LOD of 423 
this particular system can be extremely improved, offering an approach that can be extrapolated to 424 
other nanoplasmonic sensing platforms. By only exposing the highly sensitive inner walls of the 425 
nanoholes to the surrounding dielectric, the authors assure the binding of molecules to the most 426 
sensitive regions of the transducer surface (see Figure 4.A.). Furthermore, a material-selective 427 
poly(ethylene glycol)-based surface chemistry limits the binding of NeutrAvidin only to surface 428 
immobilized biotin that finds itself on the exposed gold regions. By doing this, a 20-fold enhancement of 429 
the sensor response time is reported. It should be noted that the controlled immobilization onto the 430 
gold areas with highest sensitivities is not achieved by surface chemistry but by the nanostructure 431 
fabrication process itself. The latter is done by sandwiching the gold nanohole substrate between two 432 
TiO2-layers. This strategy clearly simplifies the chemistry and reduces the complexity to discriminate 433 
between TiO2 and gold. In an alternative, but conceptually similar methodology, the same authors have 434 
developed a more complex material-selective surface chemistry protocol [109]. In this case, gold 435 
nanodisk dimers were fabricated on SiO2 substrates using bioactive TiO2 layers located in the gaps 436 
between the gold disks (see Figure 4.B.). By appropriately choosing pegylated compounds that 437 
selectively react with Au, TiO2 or SiO2, biomolecules could be immobilized exclusively in these high EM-438 
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field gaps, assuring enhanced sensitivities. When comparing this sensitivity to the case where the 439 
molecules are uniquely bound to the gold nanodisks, a four-fold larger signal per bound molecule was 440 
obtained (Figure 4.B.).  441 
Another interesting strategy takes advantage of thiol place-exchange processes. Using gold nanoplates 442 
grown on glass or silicon surfaces, Beeram et al.[110, 111], followed this procedure by first covering the 443 
surface with a non-reactive thiol. Then, subsequent addition of another thiol-modified compound (in 444 
this case incorporating a reactive carboxylic group) induces an exchange process of reagents, occurring 445 
preferentially at edge- or vertex sites of the nanostructures (which turn out to be approximately 2-3 446 
times more sensitive than terrace sites) (see Figure 4.C). Following this path, the binding of antibodies 447 
(anti-IgG) exhibited a higher sensitivity compared to the case in which the nanoplates were entirely 448 
covered with the reactive thiol group. Moreover, the detection of target IgG resulted in a LOD 500 times 449 
lower than the one obtained with conventional antibody coverage of the nanoplates, even using much 450 
higher concentrations of anti-IgG receptor molecules (10x). Also, the length of the thiol linkers, used to 451 
control the distance from the surface, have a significant effect since larger spectral shifts are obtained 452 
for short thiols [111]. 453 
Substrate Effects 454 
The required attachment of lithographically fabricated nanostructures to underlying substrates imposes 455 
significant intrinsic drawbacks on the sensing performance of LSPR sensors. To assure a robust binding 456 
of the nanostructures, often, extremely thin metal adhesion layers are employed to form a bridge 457 
between the plasmonic material and the substrate. However, the use of these metal adhesion layers 458 
increases the LSPR dephasing time, reducing the scattering amplitude and inducing peak broadening. 459 
Judging from a biosensing point of view, this aggravates the signal to noise ratio of LSPR sensors, 460 
resulting in inferior sensing performances. Therefore, a proper choice of material and geometry has 461 
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proven to be of critical importance to provide competitive sensor performances [112, 113]. In thisline, 462 
plasmonic resonances can be improved by replacing the metal adhesion layer by a thin molecular layer 463 
(i.e. (3-mercaptopropyl)trimethoxysilane) which binds both the glass substrate (through the silane 464 
group) and the metal (through the thiol group)[114].  465 
Furthermore, the supporting substrates (typically glass) possess a RI that is much higher than those 466 
corresponding to the buffer solutions normally used in bioassays. As a consequence, the symmetry of 467 
the EM around the nanostructures is broken, shifting a much larger part of this EM field towards the 468 
metal/glass interface. Here, this EM field is almost entirely insensitive to RI changes of the external 469 
dielectric medium, significantly lowering the overall sensitivity of the nanoplasmonic structures [115]. To 470 
overcome this problem and improve the sensing features of the nanostructures, the effective RI 471 
surrounding the nanostructures has to be decreased. The use of low RI materials as supporting 472 
substrates presents itself as a very straightforward method to overcome this problem. Following this 473 
route, Brian et al. showed that a Teflon (n=1.32) substrate supporting a thin gold film perforated with 474 
nanoholes yielded a 40 % improvement of the bulk sensitivity [116]. Another strategy relies on placing 475 
the nanostructures on nanopillars, distancing them with respect to the underlying glass substrate. These 476 
dielectric pillars can be created during the lithographical fabrication process [117, 118], or afterwards, 477 
using an isotropic etch of the glass substrates (see Figure 5). Following this path, all the hotspots of the 478 
nanostructures are exposed to the surrounding dielectric, increasing the particle surface available for 479 
biosensing, leading to sensitivities that are comparable to that of free nanostructures in a homogeneous 480 
dielectric medium [112]. The latter was achieved via DNA hybridization measurements.  481 
3.3 LSPR Biosensing: Applications and Issues 482 
The previous sections have highlighted fundamental aspects that researchers are implementing to 483 
improve the performance and the capabilities of nanoplasmonic biosensors. However, its transfer to 484 
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real applications is not that straightforward. When aiming at the detection of low amounts of molecules 485 
and pushing high throughput capabilities to the limit, single particle sensing is the preferred option. 486 
Currently, array-based LSPR biosensors are most commonly used. Some results reported in the literature 487 
using array-based nanostructures in which their sensing performance is directly compared to 488 
conventional SPR sensing, seem to be encouraging, while simultaneously, other publications reveal 489 
aspects of refractometric LSPR sensing that inevitably generate serious doubts about its real potential. 490 
For instance, Homola’s group developed a high-resolution LSPR setup and did some experiments on 491 
ordered nanorod arrays determining their surface coverage with DNA sequences. They concluded that 492 
although LSPR-based biosensors can detect a number of molecules (i.e. number of interactions) two 493 
orders of magnitude lower than SPR-based sensors, which is clearly advantageous, the resulting 494 
analytical performance is very similar compared to other high-resolution SPR setups [119]. This result is 495 
most probably due to the kinetics of the interaction as the probability of the biomolecular interaction is 496 
also proportional to the number of interacting molecules. Linked to this result, and putting more focus 497 
on the influence of the fluidics and the kinetics of the reaction, a recent study by Sipova et al. [120] 498 
compared the performance of SPR and LSPR-like sensors to detect interactions events in flow-through 499 
formats. The study was done by comparing a flat surface covered with receptors, resembling an SPR 500 
system, with a situation in which a single receptor is immobilized on the surface, for the detection of 501 
single binding events, being approximately analogous to an LSPR-like system. The estimation concluded 502 
that for common biomolecular interactions (antigen-antibody, DNA-DNA, etc.) and for typical detection 503 
times (10 min) the probability of positive response, that is, of detecting a single molecular interaction in 504 
the case of a single receptor (i.e. in a single nanostructure) is much lower (between 10 and 103) 505 
compared with flat surfaces homogeneously covered with receptors. The reason behind this is precisely 506 
due to the low number of recognition elements available in LSPR sensing and only seems to approach 507 
SPR performance when dissociation rates are extremely high and/or when the analytes are small. 508 
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Although for static end-point analyses these conclusions may not be the same, these results exemplify 509 
the existing debate about the real necessity of pushing forward single event detection with 510 
nanoplasmonic platforms as next-generation biosensors from a strictly practical analytical point of view. 511 
In the following we discuss some recently reported relevant works that include both the use of single 512 
nanoparticles and array-based nanostructures as sensing platforms for real biosensing experiments. 513 
3.3.1 Single Particle Sensing  514 
The detection of discrete binding events with single nanostructures has positioned itself as the ultimate 515 
goal for future biosensors which share high throughput capabilities, low sample consumption and 516 
extremely low limits of detection among their main characteristics. However, from a strict biosensing 517 
perspective, where detecting low concentrations of target is the main goal, the potential and feasibility 518 
of label-free single particle sensing is probably more limited. Whereas the spectral readout setup can be 519 
easily adapted to single particle detection using microscopy, there are still some general issues related 520 
to poor signal-to-noise ratios. Although this can be significantly improved by implementing near-normal 521 
incidence DF microscopy instead of more conventional large incidence angle schemes [121], DF 522 
microscopy generally provides low signal levels and insufficient time resolution for the detection of 523 
few/single analytes. Also, it usually results in fair sensitivities and long-time analysis [122], caused by 524 
mass transport limitations [123, 124]. Recently, by expanding a conventional DF microscopy scheme 525 
with a broadband laser source and an intensified CCD camera, Ament et al. demonstrated the label-free 526 
single protein detection with an individual metallic nanostructure [125]. Contrary to prior work, their 527 
technique offers impressive levels of time-resolution (ms time scale, with between 4 and 6 orders of 528 
magnitude better levels than previous reported works) and measurement noise (tens of pm). 529 
Furthermore, Zijlstra et al. demonstrated that the detection of individual target analytes can also be 530 
achieved by making use of photothermal microscopy [126]. Gold nanorods - biotinylated mainly at the 531 
tips [127] - were immobilized on the surface and three biotin-binding proteins with different molecular 532 
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weight were discretely detected, observing step-like signal-enhancements proportional to their sizes 533 
[126]. Also, in order to allow for multiplexed spectral interrogation of single nanoparticles, much effort 534 
is being put in devising techniques for parallel read-outs. We can distinguish techniques based on the 535 
use of conventional DF microscopy, in which the spectral readout is either carried out with the use of a 536 
liquid crystal tunable crystal [128], gratings [129], or advanced image processing algorithms [130] for the 537 
parallel spectral read-out of multiple nanostructures. The latter approach is especially interesting, since 538 
next to parallel read-out, this methodology normalizes the LSPR of geometrically different nanoparticles. 539 
This minimizes the influence of inherent differences in the same batch of nanostructures, avoiding the 540 
necessity of averaging several nanoparticles while improving fitting parameters in biosensing assays. But 541 
despite the benefits of these methods, a great challenge lies ahead in order to provide these techniques 542 
with improved signal levels, and hence, better time resolution, to make them really useful to study the 543 
real-time kinetics of surface binding events.  544 
In terms of applications, a variety of recent examples have appeared in literature. Until recently, single 545 
molecule/event detection has been restricted to the use of labels, due to the limited resolution of peak 546 
shift resolution in most common LSPR-based technologies. Amplification schemes based on the use of 547 
gold nanoparticles, which monitor single DNA hybridization events [131] have been reported. Another 548 
approach is based on exploiting the catalytic activity of the enzyme Horseradish Peroxidase (HRP), which 549 
in this proof-of-concept study was used as target itself [132]. Exploiting the catalytic activity, few or even 550 
one HRP molecule can be detected on conical nanoparticles, by adding a substrate which produces a 551 
precipitated product. The binding of the enzyme on the surface of the nanostructures induced the 552 
localization of the precipitate on the very same structure, significantly enhancing the overall signal, and 553 
improving the detectability. The strategy could be adapted to detect other type of molecules which 554 
incorporated HRP as labels in an ELISA-like assay, which inevitably prevents a label-free approach. On 555 
the other hand, strict label-free single-particle sensing has already been attempted to evaluate self-556 
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assembled monolayer formation, in this case, on silver nanoparticles [133] and also for proof-of-concept 557 
biotin-streptavidin detection either with nanoparticles [58, 134, 135] or nanoholes [136].  558 
Some examples of protein detection by immobilizing aptamers or antibodies on nanoparticle surface 559 
(either nanospheres [130, 137] or nanorods [138, 139]) have also been reported, showing its potential. 560 
In some cases, sensitivities in the attomolar range are achieved [138], although it should be mentioned 561 
that this involved end-point measurements. Huang et al. [140] have detected TNFα protein using 562 
immobilized Ag nanoparticles (2.6 nm) functionalized with its specific antibody using DF single 563 
nanoparticle optical microscopy and spectroscopy (SNOMS). Although acquisition times of several hours 564 
were necessary, the high sensitivity of these small-size NPs assured single molecule detection and the 565 
study of the binding kinetics. Song et al. [141] employed single particle sensing to study DNA-protein 566 
interaction, in particular, to estimate the relative promoter activity, by immobilizing the DNA sequence 567 
(SP6 promoter and single point mutation variants) and detect promoter Polymerases (SP6 RNA 568 
polymerase). What adds special interest to this work is that, contrary to conventional methodologies, 569 
real-time kinetics of the reaction was studied. Mayer et al. demonstrated the detection of single 570 
capturing and unbinding events using single gold bipyramids in real time, paying special attention to the 571 
dissociation rather than to the binding events, since it is slow enough to detect it in the time resolution 572 
frame, and should not be affected by initial concentration or diffusion effects [53]. The relatively long 573 
timescale of the process (105 s) turns out to be an advantage to detect single events. This approach can 574 
provide valuable fundamental information regarding nanostructure behavior and protein interaction 575 
dynamics in comparison with labeled methodologies such as FRET (fluorescence energy transfer 576 
processes) [142], which require modification of molecules and limits time scale to the stability of the dye 577 
used, being sometimes short to some purposes (i.e. 102 s). 578 
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3.3.2 Particle Array Sensing 579 
As previously discussed, whereas single particle sensing offers outstanding potential from a multiplexing 580 
point of view, and avoids inherent “signal-averaging effects” when dealing with nanostructured 581 
surfaces, this concept exhibits some important drawbacks which prevents its extensive use for routine 582 
biosensing analysis. In this regard, biosensing schemes based on arrays of nanostructures not only offer 583 
improved possibilities for cheap and mass-scale chip production, but also hold the advantage of keeping 584 
the required instrumentation very simple. It comes therefore as no surprise that most nanoplasmonic 585 
biosensing studies currently rely on the use of nanostructured substrates. As is also the case for single 586 
particle sensing, besides some relevant examples published some years ago[143, 144], the majority of 587 
recent publications keeps being limited to a proof-of-concept based on a routine biomolecule 588 
immobilization and subsequent target detection. More in-depth analyticalstudy, including a complete 589 
optimization of the bioassay to set its reproducibility, sensitivity, specificity and viability to detect 590 
targets in complex samples is yet rare to find. Besides, often end-point analyses are carried out instead 591 
of real-time measurements that monitor the reaction kinetics.  Even more, end-point measurements are 592 
generally carried out in air after performing successive incubation/washing steps, thereby inevitably 593 
affecting their reproducibility and increasing measurement times. On the contrary, in the case of real-594 
time monitoring, the use of a fluidic cell prevents the samples from drying, ensuring that biomolecules 595 
remain under favorable aqueous environment which minimizes their denaturation and also facilitates 596 
the kinetics analysis [145]. The most recent works, which are characterized by a proactive strategy that 597 
addresses one or more of these previously mentioned aspects are discussed in the remainder of this 598 
section and summarized in Table 1.  599 
When considering nanostructured arrays, one can initially distinguish between particle- and hole-based 600 
nanostructures, being the particle based one the more extensively used for nanoplasmonic biosensing. 601 
Most of publications employ antibody-based strategies, either for the detection of proteins or viruses, 602 
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DNA interactions or with more unusual approaches such as the study of supported lipid bilayer 603 
formations. Among them, some stand out for handling interesting issues related to biosensing. For 604 
instance, although no in-depth optimization has been performed, Zhou et al. used an integrated LSPR 605 
sensor based on Ag nanotriangles fabricated by NSL to detect p53 protein levels in serum from cancer 606 
patients (patients with head and neck squamous cell carcinoma, HNSCC), which is commonly 607 
overexpressed when compared to healthy patients. Specific antibody against p53 was covalently bound 608 
to the nanoparticle surface, and detection was done with incubation steps and static measurements. 609 
Unfortunately, no protocol optimization, reproducibility estimations or studies related to the influence 610 
of serum were presented. Similarly, but including real-time dynamics analysis, Chen et al. [146], 611 
demonstrated the detection of two different proteins (PSA and Extracellular adherence protein EAP) 612 
using specific antibodies immobilized on the surface of gold nanodisks. In this case, estimated LODs 613 
ranging between 1-8 pM were reported (compliant with the requirements for clinical applications). 614 
However, also in this case, neither specificity studies nor detailed assay optimization were addressed.  615 
More in-depth biosensing analyses have been reported using Au-capped nanoparticles [147], fabricated 616 
using a dense monolayer of silica nanoparticles on top of a gold substrate as a core template for the 617 
subsequent deposition of a thin Au film (tens of nm). Their ease of fabrication, strong LSPR and 618 
integration in simple optical setups yields very compact nanoplasmonic biosensing schemes which are 619 
typically based on static absorbance measurements done after intermediate incubation steps. Despite 620 
the fact that no cell- or microfluidics are employed, the assay optimization and the reproducibility 621 
studies confirm the robustness of the approach. This type of substrate has been exploited for a variety 622 
of biosensing applications, most of them with a clinically relevant goal, either using antibodies or nucleic 623 
acids as active recognition elements. A selection of successful results are gathered in Table 1, where one 624 
can highlight for instance the detection of proteins in complex media (detection of casein protein in milk 625 
with antibodies immobilized on the surface using Protein A as orienting molecule [147]). Another 626 
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remarkable example is based on the detection of cell activity and cell function (i.e. determination of cell 627 
metabolites such as Interleukin-2, IL-2). This is achieved by immobilizing specific antibodies against these 628 
metabolites. Afterwards the cells are simply deposited and appropriately stimulated in order to trigger 629 
the metabolism to produce and secrete certain molecules which can be captured by the antibody [148]). 630 
Other biosensing examples are focused on the detection of relevant biomarkers for Alzheimer’s disease 631 
using specific antibodies [149], the interaction of toxins with membranes which are immobilized on the 632 
surface [150] or fibrinogen detection, mediated by antibodies which are immobilized in an oriented 633 
manner using a specific aptamer that recognizes the Fc (constant fraction) of the immunoglobulin [151].  634 
Multiplexed analyses can be implemented through the use of biodeposition systems [152] or by 635 
adapting the fabrication to obtain multiple areas of gold-capped nanoparticles, (multispot gold-capped 636 
nanoparticle arrays, MG-NPA) which can be individually immobilized and interrogated (i.e. between 15-637 
60 spots and sizes in the mm range), assuring higher levels of throughput. This approach allowed for the 638 
detection of antigens related to the hepatitis B virus [153], the detection of antibodies recognizing 639 
influenza virus [154] or the detection of DNA point mutations related with corneal dystrophies [155], 640 
which was validated with real patients’ samples. Furthermore, Cu-capped nanostructures have been 641 
used to carry out a complete multiplexed biosensing experiment in which pathogenic bacteria DNA was 642 
directly detected in real isolates coming from samples as blood, pus, urine or sputum exhibiting 643 
sensitivities in the fM range [156]. 644 
Recently, alternative biosensing approaches based on specific recognition events have been reported 645 
that offer interesting results beyond clinical diagnosis. For instance, using self-assembled gold nanorods, 646 
the detection of chiral compounds has been showed using enantioselective sensitive receptors [67], 647 
being a good example of LSPR sensing in the field of drug-protein interactions. In this work, the 648 
nanostructures, immobilized on the inner walls of a microfluidic channel, were functionalized with 649 
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human α-thrombin that was used as the selective receptor. Then, a complete optimization of the 650 
protocol for the detection of the drug RS-melagatran was performed, achieving discrimination of the 651 
enantiomeric counterpart (SR-melagatran). Besides, although at the cost of a diminished sensitivity, the 652 
target could also be detected in human serum. This concept has been further expanded for the 653 
discrimination of a racemic mixture (in this case for (R) and (S)- 1,2,3,4,-Tetrahydro-1-naphtylamine, 654 
TNA), using weak or non-enantioselective receptors instead of strong ones. In this case, the authors 655 
used a dual channel microfluidic chip, with a weak chiral receptor in one channel and a nonselective 656 
receptor in the other one [157]. By combining the information extracted from both channels it was 657 
possible to determine the individual concentration of each enantiomer of TNA in a racemic mixture.  658 
Another biosensing concept that has been recently exploited involves the detection of conformational 659 
changes in proteins, which is more plausible to be detected using the strong EM field confinement of 660 
LSPRs than with the more deeply penetrating evanescent fields of conventional SPRs. In this case the 661 
focus does not lie on the direct detection and quantification of a specific target, but on the study of the 662 
protein structure or interactions against external stimuli or interactions with small molecules, which, 663 
due to their low molecular weight, would otherwise be difficult to detect by simply binding them to the 664 
surface. This is the case recently reported by Hall et al. [158], where Ca2+ was detected in a label-free 665 
manner, by monitoring the conformational changes of the protein calmodulin immobilized on the 666 
surface of Ag nanoprisms. The changes in the conformation affect the density and overall height of the 667 
protein immobilized layer, resulting in spectral LSPR shifts. A low-noise level (0.002 nm and S/N levels of 668 
500), together with a well-controlled immobilization of calmodulin, which ensures the proper 669 
orientation of the globular domains responsible for the interaction with the ion, resulted in Ca2+ 670 
detection at concentrations as low as 23 μM. Furthermore, the strong EM field confinement of LSPRs, 671 
which can be exploited to increase the sensitivity to detect small molecules, can be further enhanced by 672 
taking advantage of another phenomena, derived from the strong coupling between molecular 673 
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resonances of chromophores and the LSPR, resulting in larger spectral shifts [159]. This has been used to 674 
study the interaction of small drugs with human membrane-bound cytochrome P450 3A4 (CYP3A4), 675 
which contains a heme chromophore group [160]. In this work, CYP3A4 was first stabilized in the form of 676 
soluble nanodisks with membrane scaffold proteins, and then immobilized onto Ag nanoparticles. The 677 
binding of a variety of small drugs (MW~ 100-700 Da) has been tested and the observed spectral shift 678 
(blue shift, red shift or no shift) identifies different interaction types. 679 
Whereas particle arrays are solely dominated by the LSPR of the nanostructures, nanohole substrates 680 
present additional peculiarities due the co-existence of surface plasmons that propagate along the metal 681 
film and localized plasmons excited inside individual nanoholes, whose interaction can give rise to 682 
exciting optical phenomena such as Extraordinary Optical transmission (EOT) [161] or interacting anti-683 
symmetric plasmons [162]. Over the years, nanohole substrates have been extensively studied, both 684 
from a fundamental and practical point of view. Since the spectral interrogation of nanohole films relies 685 
on simple transmission measurements, thereby lacking the need of prism-coupling, and hence, 686 
noticeably simplifying the optical measurement schemes [163, 164], their use for biosensing has been 687 
widely suggested [165-169]. Similarly to particle-array this particular measuring scheme is also 688 
compatible with imaging configurations [3], opening up facile routes towards multiplexed sensing 689 
assays, as demonstrated in some biosensing applications, including quantification of ovarian cancer 690 
biomarkers with an integrated microfluidic platform[170], studies of antibody-ligand binding kinetics 691 
[166] or simultaneous detection of antibody-target binding events in temperature regulated flow cells in 692 
microarrays based substrates [171]. However, these measurements generally tend to exhibit moderate 693 
sensitivities, even lower than SPR-based biosensors, as demonstrated in these previous examples (in the 694 
nM range [166, 170]. Better sensing performances for high throughput measurements can be achieved 695 
introducing dual-color filter imaging [90], resulting not only in better sensitivities, but also in increased 696 
accuracy and signal-to-noise ratios. On the other hand, when studied in a conventional Kretschmann 697 
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configuration it turns out that these nanohole array films exhibit enhanced bulk sensitivities compared 698 
to planar gold surfaces. These sensitivity enhancements can be precisely tuned using the periodicity of 699 
the holes and their geometry as variables [172], although resulting in lower resolutions [173]. Besides 700 
this enhancement of sensitivity on thin gold film, strong localized plasmons are generated in the hole 701 
[174-176], providing an enhanced sensitivity in these areas. Due to the coexistence of propagating and 702 
localized excitations at the same time, the behavior of these LSPRs is quite complex being the shape and 703 
size of the hole, the lattice periodicity and the substrate material important parameters governing both 704 
phenomena [116, 167, 177]. Biosensing schemes that exploit the LSPRs excited in the nanohole itself 705 
possess the attractive advantage of minimizing the required sample volumes, as long as accurate 706 
immobilization in these areas occurs. The resulting reduction of the sensing area will eventually proclaim 707 
better sensitivities, opening up pathways towards very low LODs [163]. Besides the biosensing examples 708 
described above, other relevant applications have been based on the formation of supported lipid 709 
bilayer (SLB) formation. The addition of a silicon-based layer over nanohole structures permits the 710 
formation of SLB and has allowed studies that involve cell membrane related biorecognition reactions 711 
[178, 179]. Besides, SLBs have been used as myelin-mimicking bilayers to kinetically characterize 712 
autoantibodies involved in neurological disorders [180]. Nevertheless, as of today, the advancements 713 
made in the fabrication of these nanoholes structures and the reported studies that discern their optical 714 
features have not been fully transferred to a routinely used biosensing scheme and the majority of the 715 
examples in the literature do not surpass the proof-of-concept level in which a simple 716 
biofunctionalization of the surface followed by a preliminary detection assay is carried out, thereby fully 717 
neglecting any further optimization of the addressed biosensing assay.  718 
Currently, one of the most promising uses of nanohole arrays for the creation of refractometric 719 
nanoplasmonic sensors relies on suspending these structures, such that the holes act as nanochannel-720 
based structures. In this configuration, the analytes are forced to flow through the nanometer-sized 721 
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sensing channels, where the nanohole concentrates the most sensitive areas. This approach does not 722 
only enhance the analyte delivery, but also improves the binding efficiency and reduces the sample 723 
consumption. Gordon’s group [181-183] demonstrated the applicability of these structures as 724 
optofluidic sensors achieving a significant enhancement in adsorption kinetics compared with flow-over 725 
strategies and a 2-fold LOD improvement by concentrating the target in the nanohole proximity [184]. 726 
Biosensing was demonstrated as proof-of-concept by binding an antibody to a previously functionalized 727 
surface. Real time measurements can be performed due to the introduction of a fluidic cell integrating 728 
the sensing structure. Altug’s group designed a very similar structure with a bulk sensitivity of 535 729 
nm/RIU [185]. Furthermore, a 14-fold improvement in the mass transport rate constants was achieved 730 
[186]. Virus detection based on the immobilization of specific antibodies onto the surface (not restricted 731 
to the in-hole section but over all the metal surface) has been demonstrated with this design, although 732 
the measurements were based on end-point analyses, requiring long-time incubations (60-90 min) and 733 
no microfluidics were used [187]. Hook et al. have also fabricated so-called nanopores based on 734 
suspended arrays of nanoholes [188]. However, besides the optimization of the structure and its 735 
characterization, these authors have devoted a great effort in the controlled functionalization of gold 736 
areas while protecting the rest of the substrate (SiN) from non-specific adsorptions: the use of 737 
appropriate antifouling compounds such as pegylated compounds with thiols or with poly-lysines, allow 738 
the particular binding to each region (gold or silicon, respectively), thereby minimizing nonspecific 739 
adsorptions. If the thiol-pegylated compounds also contain additional functionality (i.e. biotin groups), 740 
subsequent biofunctionalization can take place and can be controlled at the areas of interest (gold and 741 
not silicon). These experiments showed a 10-fold faster response as compared with non-suspended 742 
holes with diffusion-controlled binding.  743 
35 
 
3.4 Integration, Microfluidics and Multiplexing  744 
Despite the reported advantages of LSPR-based sensors in terms of multiplexing and integration, only 745 
few works have dealt with these aspects. So far, to our knowledge, only one product has reached 746 
commercial implementation [189]. Lamdagen Corporation has launched a device based on LSPR for 747 
laboratory use. The device allows real time measurements using syringe pumps and nanostructured 748 
metallic films as sensing chips. Four or eight-spot arrayed substrates can be used which can be 749 
simultaneously monitored, yielding a medium degree of throughput. The device consists of light sources 750 
connected to optical fibers to direct the light onto the surface and output optical fibers which collect the 751 
reflected light directly to individual spectrometers, permitting individual channel monitoring. The 752 
equipment also incorporates software to analyze the data. The reproducibility and robustness of the 753 
system seems to be high and complex media such as serum and saliva can be analyzed. Despite this 754 
potential, the sensitivity levels in a label-free configuration without the aid of amplification are still fair, 755 
lying in the nM range. Nevertheless, this is an interesting example of integration LSPR system, and can 756 
be considered an initial step towards point-of-care devices.  757 
Nanoplasmonic point-of-care devices inevitably require three crucial aspects: compactness, ease-of-use 758 
and potential for high-throughput. Removing the need of a spectrophotometer and using light emitting 759 
diodes (LEDs) as LSPR excitation source can specifically contribute to simplification of the system, as 760 
recently demonstrated by Huang et al. [190]. The authors have designed a setup where a LED (λ=530 761 
nm) is used for plasmon excitation, while a quadrant photodetector is used to continuously measure the 762 
change of the transmitted light at a fixed wavelength (see Figure 6.A.). Dual-channel microfluidics (for 763 
sample and reference) has been fabricated and integrated with the nanoplasmonic chip. This flow cell 764 
incorporates an automated sample delivery system consisting of an off-chip micropump and microvalves 765 
[191]. Calibration curves of the interaction of Anti-biotin antibody to biotin-coated nanoparticle surface 766 
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were demonstrated as proof-of-concept, although with limited sensitivity, mainly due to the properties 767 
of the substrate (gold nanoparticles that rendered a sensitivity of 10-4 RIU and a LOD of 270 ng/mL of 768 
antibody).  769 
A similar approach was presented by Neuzil et al. [192], in which a palm-size reflectance-based LSPR 770 
sensing scheme was fabricated, that also uses LED illumination and a photodiode-based detection 771 
scheme, yielding a simplified setup (see Figure 6.C.). In this case, instead of a single LED, four different 772 
LEDs were combined, to improve either data normalization or to simply allow for a more efficient 773 
selection of the most suitable one for a specific application. The reflected light coming from each LED is 774 
lead to a single photocurrent output, after which the signals are de-multiplexed and digitized, before 775 
being displayed on an incorporated LCD display. Although the device undoubtedly shows good potential 776 
for future point-of-care devices, the lack of incorporated microfluidics forces the measurements to be 777 
based on static incubation. However, up to this moment, no biosensing demonstration of this device has 778 
been presented.  779 
More recently, another portable transmission-based nanoplasmonic sensor has been reported [193], 780 
based on the use of three individual LEDs combined with on-board signal amplification (Figure 6.B). This 781 
scheme uses the monitorization of spectral LSPR shifts, using an algorithm that extracts the spectral 782 
position of the resonance both before and after molecular interaction events. Immobilization of single-783 
stranded DNA was carried out as a proof-of-concept. However, the straightforward subsequent 784 
detection of complementary target has not been yet tested, and moreover, the measurements were 785 
performed in air under static conditions. Also aiming at increasing the compactness of the sensing 786 
devices, Mazzota et al. [194] have presented an integrated detection based on the use an array of small 787 
photoactive diode regions (i.e. silicon p/n junctions) that act as independent photodetectors. In this 788 
case, two of them have a nanostructure patterned on their surface (nanodisks on Si3N4 coated glass), 789 
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while the other two are used as references. Changes in the extinction spectra caused by binding 790 
interactions then result in real-time measurable changes of the photocurrent output. By incorporating 791 
the nanoplasmonic chip in a flow cell, its biosensing capability was shown by preparing a biotinylated 792 
surface and subsequently monitoring the real-time binding of Neutravidin. Furthermore, also 793 
implementation of a Vertical-cavity surface-emitting laser (VCSEL)- optical excitation, combined with a 794 
CCD camera for detection, significantly reduces the dimensions of the setup [195]. In this work, the 795 
biosensing measurements based on the study of biotin-neutravidin interactions, showed similar 796 
outcome when compared to the use of a spectrophotometer.  797 
The advantage of using a CCD camera for multiplexed measurements with an LSPR-based device has 798 
recently been demonstrated by Ruemmele et al. [196]. They have reported the first example of full 799 
spectral imaging of a macroscale LSPR sensor array by modifying and adapting a commercial SPRi with a 800 
liquid crystal tunable filter (LCTF), a flow cell and by aligning the camera with the illumination path (See 801 
Figure 6.C.). The LCTF, which is used to filter the white light illuminating the nanoplasmonic chip, 802 
enables the monitorization of either visible or near-IR wavelengths. While scanning, a camera 803 
simultaneously captures images whose intensity maps are then correlated with wavelength, enabling 804 
the extraction of region-specific LSPR spectra, whose spatial resolution is theoretically diffraction-805 
limited. Substrates with sizes of 6.45 cm2 containing different nanodisks areas, which can be individually 806 
biofunctionalized and monitored were fabricated. Simultaneous binding measurements could be 807 
performed over an area of around 1.1 cm2 and as proof-of-concept two approaches were demonstrated: 808 
(i) homogeneous coverage of the nanodisk surface with biotin at a unique concentration and anti-biotin 809 
detection at different concentrations, using static measurements whose results yielded a calibration 810 
binding curve; (ii) the controlled immobilization at different areas using different DNA probe 811 
concentrations and a subsequent in-flow delivery of the complementary sequence at a single 812 
concentration; in this case, multiplexing throughput is incorporated under dynamic conditions. Although 813 
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not compact enough to be denominated as “lab-on-chip”, this is an attractive approach that attempts to 814 
expand LSPR sensing with multiplexed capabilities, similar to the transition of SPR to SPRi.  815 
The previous examples aim at the integration of the optical components and those needed for the 816 
different detection read-outs; in this regard, some of them use static measurements while others allow 817 
for in-flow sample injection via the use of custom-made single-channel flow cells.  818 
However, the successful implementation of more complex microfluidics, that assure both 819 
miniaturization and improved throughput capabilities, still remains a challenging task. In literature some 820 
examples can be found of nanoplasmonic biosensing with more elaborated PDMS microfluidics, ranging 821 
from a few fluidic channels, (1-2 channels [197, 198]) to high throughput chips (nanohole substrate with 822 
50 channels monitored in parallel by a CCD camera [199]). Next to PDMS, other polymeric materials 823 
offer more compatibility with mass production and low-cost fabrication such as cyclic olefin copolymer 824 
(COC). COC has profiled itself as an interesting alternative material for the fabrication of microfluidic 825 
systems, illustrated by the previously described dual-channel system designed by Huang et al. [190]. A 826 
more complex configuration that incorporates up to 64 differentiated incubation chambers is described 827 
by Malic et al. [200]. They have designed and fabricated monolithic thermoplastic microfluidics which is 828 
based on three layers: the nanostructured bottom layer (flow layer), which, next to the chambers (8x8) 829 
and the fluidic channels, also incorporates the plasmonic nanostructures (nanogratings); the top layer 830 
(control layer) which is built out of a thermoplasmic elastomer (TPE) and allows the integration of 831 
reservoirs and active fluidic elements such as an array of pneumatic valves to ensure the delivery of 832 
fluids; finally, an intermediate membrane whose main function is the assembly of the entire device. This 833 
apparatus operates under pressure driven flow supplied by a multichannel syringe pump equipped with 834 
switching valves for sample loading. The design allows both differentiated functionalization and 835 
detection in a row/column configuration. This is done by opening/closing the corresponding valves of 836 
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each functionalization/sample loading channel in such a way that up to 64 different conditions can be 837 
tested. The experimental setup is designed to perform sequential transmission measurements, by using 838 
a XYZ rotational stage to individually align the illumination source with each chamber. The authors have 839 
characterized the device in terms of bulk sensitivity and more interestingly, they have done kinetic real 840 
time measurements for the detection of CD44, a clinically relevant biomarker. They have monitored all 841 
the steps, from the surface derivatization with a thiol-based reagent, to the attachment of specific 842 
antibody anti–CD44 and the subsequent detection of CD44 at different concentrations, enabling the 843 
determination of binding and affinity constants. Direct detection (with a LOD of 5.26 nM) and also 844 
amplification with a secondary antibody to improve sensitivity (up to a LOD of 10.53 pM) were 845 
performed, with reproducibility studies included. This impressive high-throughput approach would gain 846 
additional merit, especially when viewed from a POC perspective, if parallel read-out of all chambers 847 
could be performed.  848 
4. Considerations, Future Trends and Conclusions 849 
As reflected in this review, the work published in the field of refractometric nanoplasmonic biosensing is 850 
often of a very fundamental nature. Without a doubt, the main reason behind this is the relative youth 851 
of this ever-expanding field of research. Examples in literature of nanoplasmonic sensing schemes that 852 
report interesting biosensing capabilities are typically accompanied by novel nanoplasmonic structures 853 
that often rely on new material properties. In most cases, the novelty of these new materials relegates 854 
their use as biosensing platforms to a secondary plane. In this regard, these studies are often 855 
accompanied by – far from optimized – preliminary proof-of-concept biosensing assays.  856 
Several of these works clearly illustrate the great potential offered by nanoplasmonic structures as 857 
biosensing platforms. On this subject, one should emphasize several - previously discussed - studies at a 858 
single particle level that attribute better sensing performances to specific nanoparticle geometries, such 859 
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as nanorods, when compared to conventional SPR sensors. The most eye-catching example is 860 
undoubtedly the successful accomplishment of single-molecule detection, often considered the most 861 
important milestone of nanoplasmonic sensing. However, the voluminous and expensive experimental 862 
setups needed for the spectral interrogation of single nanoparticles, infringes the demands required for 863 
the creation of compact and low-cost platforms that can be used out of the laboratory.  864 
To achieve the latter, more opportunities are offered by sensing schemes based on nanostructured 865 
substrates, which, accompanied by facile experimental setups, possess much more opportunities for the 866 
fabrication of compact and integrated devices, with real possibilities of technological transfer into 867 
commercial products. However, on the downside, the reported biosensing performances of 868 
nanoplasmonic sensors based on this concept are typically of the same order as standard SPR sensors 869 
[97], thereby not adding any significant benefits when it comes to sensing performance. Although this 870 
can be compensated by other interesting properties, like miniaturization, integration and multiplexing 871 
capabilities, the sensitivity typically is considered the key factor that makes or breaks the potential of a 872 
sensing scheme.  873 
During the last lustrum, an ever increasing scientific interest can be observed involving the use of 874 
plasmonic metamaterials for sensing purposes. These metamaterials, consisting of precisely tailored 875 
nanostructured substrates that exhibit optical properties not seen in nature, can give rise to exciting 876 
optical responses with high FOM-values, suggesting their potential use as nanoplasmonic sensing 877 
platforms. In this category, a special interest goes out to Fano resonances, that is, optical modes caused 878 
by interference of continuum broad optical modes and strong localized plasmons. The optical modes are 879 
excited in precisely engineered or even self-assembled nanostructures [201], and exhibit either sub- or 880 
super-radiant optical modes with asymmetric and sharp spectral fingerprints [202], making a strong 881 
argument for their employment as refractometric biosensing schemes [105, 106, 203-209]. Also, 882 
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metamaterials based on ordered arrays of nanoparticles, which support a guided mode which can be 883 
caused either by near-field interactions or diffractive far-field effects, have appeared to be interesting 884 
for refractometric sensing applications [88, 89, 210-213]. Furthermore, also arrays of randomly ordered 885 
gold nanodisks have been shown to act as thin layers of meta-atoms with very high effective RI, allowing 886 
the guidance of in-plane EM modes [214]. Through the use of these guided modes, the overall 887 
biosensing performance of isolated gold nanodisks can be improved by more than one order of 888 
magnitude, which was shown with direct label-free antibody detection.  889 
However, also in works involving metamaterials, the focus is typically pin-pointed on the novelty of the 890 
material itself, whereas the presented biosensing evaluation (if presented) is often under-highlighted 891 
and relegated to a secondary role. We have no doubt that this situation will change in the next ten to 892 
fifteen years, but it will not be until then, that nanoplasmonic sensors will reach a point where their 893 
massive use as commercial biosensing platforms becomes attractive. In order to accelerate this 894 
technology-transfer process, we argue that more research effort should be focused on one of the most 895 
underexposed aspects of nanoplasmonic biosensing: the surface chemistry. As discussed in this review, 896 
proper biofunctionalization of the surface (with or without complementing microfluidic systems) has led 897 
to significant sensitivity enhancements of nanoplasmonic sensing platforms, mainly caused by 898 
suppressing non-specific interactions of molecules and forcing biomolecular interactions to take place 899 
solely at EM hot-spots of the nanostructures. Examples that point towards this direction are still few in 900 
number.  901 
Therefore, in order to dethrone conventional SPR sensing (and its well-studied planar surface 902 
chemistry), the current knowledge of nanoparticle biofunctionalization should expand drastically. It will 903 
not be until then that, when accompanied by low cost and large-scale fabrication techniques, 904 
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commercial nanoplasmonic sensing platforms with integrated microfluidics hit the market, and should 905 
be considered as viable technological alternatives for conventional SPR sensors. 906 
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Tables 
 
Table 1. Examples of LSPR biosensing assays 
Substrate Features Bioassay Sensitivity/LOD Ref. 
Au Nanoholes  Flow-through nanoholes; static 
measurements in air 
 
 Viruses (VSV, Ebola and Vaccinia) 
 Direct detection with Ab oriented via Protein G 
 Cell-growth media measurements 
10
6
 -10
9
 pfu/mL- [187] 
Au Nanoholes  
 
 Flow-through nanoholes ; real-time 
measurements 
 Controlled gold surface modification 
preserving SiN from nospecific adsorption 
 
 Neutravidin binding 
 Biotin-PEG immobilized on gold 
n.r. [188] 
Au Nanoholes  
 
 Non-suspended nanoholes.  
 Flow real-time measurements 
 SiOx layer on top of gold 
 
 Study of supported lipid bilayer (SLB) formation  
 Protein binding 
 Conformational changes  
n.r. [179] 
Au Nanoholes  Non-suspended nanoholes.   Autoantibodies detection on SLB n.r. [180] 
56 
 
 Flow real-time measurements 
 SiO2 layer on top of gold 
 
 Complete kinetics characterization 
Au nanodisks  Flow real-time measurements 
 No specificity studies 
 Not detailed assay optimization 
 
 Extracellular adherence protein (EAP) 
 Direct detection with Ab 
8pM (estimated) [146] 
 
 Prostate specific antigen (PSA) 
 Direct detection with Ab 
1pM (estimated) 
Au nanodisks  Flow cell to deliver samples 
 Static measurements after incubation 
 No specificity studies 
 Not detailed assay optimization 
 Prostate specific antigen (PSA) 
 Direct detection with Ab 
>280 pM [81] 
 Sandwich assay + substrate precipitation 83 fM (3pg/mL) 
Au capped NPs  Static measurements after incubation  Casein detection in milk 
 Direct detection with Ab oriented via Protein G 
10 ng/mL [147] 
Au capped NPs  Static measurements after incubation  IL-2 secreted from cells after stimulation 
 Direct detection with Ab Oriented via Protein A 
10 pg/mL [148] 
Au capped NPs  Static measurements after incubation  Tau protein detection in  
 Direct detection with Ab oriented via Protein G 
10 pg/mL  [149] 
Au capped NPs  Static measurements after incubation  Melittin (peptide toxin) 10 ng/mL [150] 
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 Interaction study with Hybrid bilayer membrane 
(HBM) 
Au-capped NPs  Static measurements after incubation  Fibrinogen 
 Direct detection with Ab oriented via RNA 
aptamer which recognizes Fc fraction 
 
0.1 ng/mL [151] 
Au-capped NPs 
(Multispot) 
 Static measurements after incubation 
 Sequential spot measurement 
 Antibody against Avian influenza antigen (AIa) 
 Gold binding preptide-AIa fusion protein (GBP-
AIa) immobilized on the surface 
1 pg/mL [154] 
Au-capped NPs 
(Multispot) 
 Static measurements after incubation 
 Sequential spot measurement 
 Hepatitis B (HB) antigen (HBsAg) detection 
 GBP-scFv fusion protein immobilized on the 
surface 
100 pg/mL [153] 
 Anti-HBsAg deetection 
 GBP-HBS-Ag fusion protein immobilized on the 
surface 
1 pg/mL 
Au-capped NPs 
(Multispot) 
 Static measurements after incubation 
 Sequential spot measurement 
 Real samples analysis 
 Single point mutation detection of BIGH3 gene 
(related to Corneal Dystrophy)  
 Complementary sequence immobilized 
1pM target DNA [155] 
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Cu-capped NPs 
(Multispot) 
 Static measurements after incubation 
 Sequential spot measurement 
 Real samples (Clinical Isolates) 
 Bacterial DNA detection 
 Complementary sequence immobilized 
10 fM target DNA [156] 
Au NPs  Static measurements after incubation 
 
 Stazonolol (steroidal hormone) detection  
 Indirect competitive immunoassay with specific 
Ab 
2.4 nM [215] 
Au deposited on 
nanoporous 
structure 
(Anodicaluminum 
oxide substrates 
AAO) 
 Static measurements after incubation 
 
 CRP detection  
 Direct detection with Antibody immobilized 
1 fg/mL [216] 
Ag NPs  Static measurements  P450 Cytochrome (CYP3A4) interaction with 
drugs CYP3A4 stablized and immobilized on NP 
Qualitative [160] 
Ag nanotriangles  Static measurements after incubation 
 Serum samples 
 No optimization 
 Detection of p53  
 Direct detection with Antibody immobilized 
n.r [217] 
Au nanorods  Flow cell to deliver samples  Enantioselective detection of RS-melagatran 0.9 nM of RS- [67] 
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 Static measurements after incubation 
 Reproducibility studies 
 Chiral recognition using human α.thrombin  
 Serum matrix studies 
 
melagatran 
Au nanorods  Flow cell to deliver samples 
 Static measurements after incubation 
 Reproducibility and accuracy studies 
 Chiral discrimination of racemic mixture of TNA 
 Protein immobilized on the surface or  
 Specific antibody immobilized on the surface 
20-100 nM of chiral 
TNA(depending on 
the receptor) 
[157] 
Ag nanoprisms  Flow real time measurements  
 Accurate surface immobilization for 
correct orientation 
 Conformational changes of calmodulin  upon ion 
interaction  
 Cqalmodulin-ligand interaction study 
 Kinetics studies of the conformational change 
600 fmol Ca
2+
/cm
2
 
23 μM of Ca
2
 
[158] 
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Figure Legends 
Figure 1. Schematics showing the detection principle of plasmonic biosensors based on (A) Surface 
Plasmon Polaritons (SPPs or SPRs) propagating along the interface of a metal and a dielectric. (B) 
Localized Surface Plasmon Resonances (LSPRs) strongly confined to the surface of sub-wavelength metal 
nanostructures. 
Figure 2. Scientific publications centered on the topic of nanoplasmonics (1990-2012). Source: Web of 
Knowledge. 
Figure 3. Diagrams illustrating nanostructure-based biosensing setups: (A) Extinction measurements, (B) 
Dark-field microscopy and (C) Total Internal Reflection (TIR) microscopy. 
Figure 4. Examples of controlled directed functionalization of metal nanostructures (A) Gold nanoholes 
of TiO2 functionalized with different surface-selective compounds. The control on the modification of 
the most sensitive material (gold) leads to signal enhancement [108]. (B) Controlled binding on the 
hotspots (between two gold nanodisks) and comparison with whole gold nanodisk surface. A 4x signal 
per molecule enhancement is achieved [109]. (C) Wavelength shift achieved on gold nanoplates after 
IgG binding on the terrace or in the edges (more sensitive areas) [111]. Reproduced from [108, 109, 
111]. Copyright (2010, 2012 and 2011) American Chemical Society. 
Figure 5. Schematic representation of short-range ordered arrays of gold nanodisks located on isotropic 
dielectric pillars, providing a strategy that can be used to increase the refractometric sensing 
performance of these nanostructures [112]. Single stranded DNA molecules attached to the nanodisks 
are used as receptor probes for the specific detection of complementary DNA strands. 
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Figure 6. Examples of integrated LSPR systems. (A) Microfluidics with two cells, the setup scheme and 
the automated sample delivery system [191]. (B) Compact small size transmission based LSPR using 
three LEDs as light source. The system incorporates the sample and photo detector [193]. (C) Palm-size 
reflectance-based LSPR with four LEDs as light source and a photodiode as detector. It incorporates a 
LCD touch screen display [192]. Reproduced from [191-193],  Copyright (2008) American Chemical 
Society. 
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